Everyone deserves access to the knowledge that shapes their health and their future.
Our Story
We are on a mission to empower individuals and families through accessible, clinical-quality genetic testing, education, and genuine expert support. Putting informed health decisions and precision care within reach for all is a driving force for our Founder.
Genotype Health was born from personal experience. Born with a rare genetic disorder, our founder knows firsthand the uncertainty, exhaustion, and emotional weight of navigating complex health conditions.
That experience, combined with a career fighting to improve healthcare access across Australia, Asia, and Papua New Guinea, led her to one clear truth: when people are informed, they make better decisions.
Genotype Health exists to help people make informed, confident decisions about their health, and to support clinicians with the diagnostic testing and genetic counselling they need to deliver precision medicine.
Everyone - regardless of their background, their country of origin, or their access to resources - deserves to understand their own genome and how that impacts their health. That knowledge can change, and in some cases save, lives.
The quest for genomic equity
We are building the Genotype Foundation so that no community is left out of the science that could save their lives.
More than 4 billion people are still underrepresented in the genetic data used to guide personalised healthcare and precision medicine
Modern genomics faces a major representation gap, with most genetic research still based primarily on people of European ancestry:
- ~80% of global genetic research data is derived from white (European-ancestry) populations
- Less than 10% comes from East Asian populations
- Less than 2% comes from African populations
- Indigenous Australians, Melanesians, and Polynesians represent a negligible fraction of the global genomic dataset
This imbalance has real consequences — for diagnosis, treatment, and patient outcomes across the world.
When genetic data lacks diversity, test results become less reliable for underrepresented groups. One of the most significant consequences is the rate of Variants of Uncertain Significance (VUS) — results that are clinically uninformative and leave patients without the answers they need.
3.4 Million Undiscovered Variants — From Just 426 Genomes
When the Human Heredity and Health in Africa (H3Africa) consortium sequenced just 426 African genomes, researchers uncovered 3.4 million previously unknown genetic variants. A separate 2018 analysis of 910 African genomes identified 300 million base pairs of DNA that had never been studied
The science we haven't yet explored may hold answers that could change medicine forever.
Real Consequences: Missed Discoveries and Medication Risks
Studying diverse populations doesn't just improve equity — it drives medical innovation.
Every under-researched population represents potential breakthroughs waiting to be found.
Why This Matters for You
If you are of non-European ancestry, current genetic testing may be less likely to give you clear, actionable answers — not because of anything about you, but because the science hasn't caught up with the diversity of humanity.
That's why we designed our population-tailored panels
Team

Mimi Zilliacus

Dr Mona Saleh
